STXBP5 and neoplasm: Notably, we observed the sphere formation efficacy was significantly compromised by STXBP5-AS1 with concurrent downregulation of stemness markers including Sox2, Bim1, Lin28 and Nanog. The suppressed stem cell-like properties were especially validated by the limiting dilution of xenograft tumor incidence.